Naloxone Nasal Spray Pharmacokinetic Study

NCT01622504 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Opioid Overdose

Interventions

DRUG: MVP005
DRUG: MVP005
DRUG: Naloxone hydrochloride solution for injection with mucosal atomization device

Sponsor

Mitovie Pharma Ltd